Table 5

Number of men consented to the APCaRI 01 and 03 protocols (1 July 2014 to 30 June 2019) who donated biospecimens and PROM data to the APCaRI Biorepository and Registry respectively, at baseline and years 1–4, categorised by therapy type

	Active surveillance	Radical prostatectomy	Radiation therapy	Hormone treatment	Cryotherapy	Total n=
Number of patients	467	958	725	697	154	3001
Baseline biospecimens	463	941	716	686	152	2958
Biospecimens year 1–4	543	1274	750	706	229	3502
Number of patients with disease progression	167	188	63	157	56	631
Disease progression biospecimens available	167	188	63	155	55	628
Baseline QoL	454	925	708	675	147	2909
QoL year 1–4	741	1638	1101	1011	285	4776

APCaRI, Alberta Prostate Cancer Research Initiative; PROM, patient-reported outcome measures; QoL, quality of life.